On demand events

<5 minutes

AAAAI 2023 I Progression of Type 2 Inflammatory Diseases in Dermatology, Pulmonology, and Gastroenterology: From Childhood to Adolescence

Fred Ghali, MD, PhD Dr. Fred Ghali discusses the impact of type 2 inflammation and barrier disruption on pediatric patients with atopic dermatitis.  

Topic: Burden Of Disease Pathophysiology Co-existing Type 2 Inflammatory Diseases

Tags: Atopic dermatitis  CRSwNP  Disease burden  Pathophysiology  Type 2 inflammation  Video  EoE  Asthma  Events  Pediatric  Disease progression 

AAAAI 2023 I Progression of Type 2 Inflammatory Diseases in Dermatology, Pulmonology, and Gastroenterology: From Childhood to Adolescence

Impact of Barrier Disruption and Type 2 Inflammation in Pediatric Patients With AD

Fred Ghali, MD, PhD
Dr. Fred Ghali discusses the impact of type 2 inflammation and barrier disruption on pediatric patients with atopic dermatitis.

 

Please rotate you device for optimal viewing

Welcome to the ADVENT program website

ADVENT is a medical education program by Sanofi and Regeneron. This website is intended only for health care professionals in the US only.

I AM A HEALTHCARE PROVIDER
I AM NOT A HEALTHCARE PROVIDER

ADVENT is a global medical education program by Sanofi and Regeneron and is only intended for healthcare providers.

You are leaving the ADVENT program website

Sanofi Genzyme does not review or control the content of non–Sanofi Genzyme websites, and this hyperlink does not constitute an endorsement by Sanofi Genzyme of the site’s content. Sanofi Genzyme’s privacy procedures do not apply to the owners of a non–Sanofi Genzyme website.

LEAVE THIS SITE GO BACK TO ADVENT PROGRAM
x

STAY IN THE KNOW

Would you like to receive updates on new ADVENT content, courses and events when available?

SUBSCRIBE

MAT-US-2104233 Exp 04/26/2023

x

Congratulations, you are now subscribed successfully.

You will receive a confirmation email at the address you provided.

If you don’t receive it, please check your spam.